Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Opinion Articles

Latest Opinion Articles

A DR-TB patient holding her daily dose at the Directly Observed Therapy corner, where patients pick up medicines for daily intake, in the Chimbay district of Karakalpakstan, Uzbekistan. Photograph by Alpamis Babaniyazov
Opinion article
Opinion article |
12 May 2016
Tuberculosis
Uzbekistan

Shorter regimens offer new hope to adults and children with MDR-TB by halving treatment time

Nurses check each other's PPE as the prepare to enter the high-risk zone in MSF's Ebola treatment center in Sierra Leone. Photograph by Anna Surinyach
Opinion article
Opinion article |
14 January 2016
Tropical & neglected diseases

The long shadow of Ebola

Metro advertisements for Doctors Without Borders, 2015. Photograph by Drew Angerer
Opinion article
Opinion article |
24 July 2015
Intellectual property and trade

TPP: Don’t trade away health

5 min
Metro advertisements for Doctors Without Borders, 2015. Photograph by Drew Angerer
Opinion article
Opinion article |
24 July 2015
Intellectual property and trade
Democratic Republic of the Congo

Why the TPP trade deal is a threat to public health

5 min
Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today. Photograph by Sydelle Willow Smith
Opinion article
Opinion article |
18 June 2015
Research and development

A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape, South Africa.. Photograph by Sydelle Willow Smith
Opinion article
Opinion article |
10 April 2015
Research and development Tuberculosis

TB Patients Take the Stage: Now for an R&D Model That Meets Their Needs

3 min
Opinion article |
13 November 2014
Tuberculosis

Mind the Deadly Gaps

MSF social worker hugs a migrant girl Photograph by Christina Simons
Opinion article
Opinion article |
16 October 2014
Intellectual property and trade

TPP: Still a Terrible Deal for Poor People's Health

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury